Cargando…
Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC
Patients diagnosed with triple negative breast cancer (TNBC) have an increased risk of rapid metastasis compared to other subtypes. Predicting long-term survival post-chemotherapy in patients with TNBC is difficult, yet enhanced infiltration of tumor infiltrating lymphocytes (TILs) has been associat...
Autores principales: | Brockwell, Natasha K., Rautela, Jai, Owen, Katie L., Gearing, Linden J., Deb, Siddhartha, Harvey, Kate, Spurling, Alex, Zanker, Damien, Chan, Chia-Ling, Cumming, Helen E., Deng, Niantao, Zakhour, Jasmine M., Duivenvoorden, Hendrika M., Robinson, Tina, Harris, Marion, White, Michelle, Fox, Jane, Ooi, Corinne, Kumar, Beena, Thomson, Jacqui, Potasz, Nicole, Swarbrick, Alex, Hertzog, Paul J., Molloy, Tim J., Toole, Sandra O’, Ganju, Vinod, Parker, Belinda S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715634/ https://www.ncbi.nlm.nih.gov/pubmed/31482136 http://dx.doi.org/10.1038/s41698-019-0093-2 |
Ejemplares similares
-
Intratumoral administration of the Toll‐like receptor 7/8 agonist 3M‐052 enhances interferon‐driven tumor immunogenicity and suppresses metastatic spread in preclinical triple‐negative breast cancer
por: Zanker, Damien J, et al.
Publicado: (2020) -
Discriminating the earliest stages of mammary carcinoma using myoepithelial and proliferative markers
por: Duivenvoorden, Hendrika M., et al.
Publicado: (2018) -
Prostate cancer cell‐intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone
por: Owen, Katie L, et al.
Publicado: (2020) -
High-content siRNA 3D co-cultures to identify myoepithelial cell-derived breast cancer suppressor proteins
por: Duivenvoorden, Hendrika M., et al.
Publicado: (2021) -
Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer
por: Meyer, Braydon, et al.
Publicado: (2021)